Lemon Tree Hotels plans to split its business after Warburg Pincus agreed to buy a 41% stake in its subsidiary, Fleur Hotels, in January 2026. While the deal values Fleur at USD 1 billion, Lemon Tree shares fell 22% since 7 January. The demerger aims to unlock value for shareholders.
Welcome to the latest edition of the Special Situations Alert. In the past we have discussed Restaurant Brands Asia (RBA) and Triveni engineering & Industries Ltd among other special situations that corporates are going through. Today, we dive into a widely watched special situation evolving at one of India's leading hotel companies.
In 2006, Warburg Pincus invested in a young Indian hotel company that had opened its first 49-room hotel only two years earlier. That company was Lemon Tree Hotels. After 13 years as an investor, Warburg sold out completely in 2019 as the company got listed.
In January 2026, Warburg came back. But not to Lemon Tree. It agreed to buy APG's 41% stake in Fleur Hotels, the Lemon Tree subsidiary that owns most of the group's hotel assets. It also agreed to put up to ₹960 crore of fresh money into Fleur, at a valuation of USD 1 billion, or about ₹9,600 crore.
The same day, Lemon Tree's board approved a plan to split the company in two. Fleur will list separately. It gets the hotel assets, the debt and the development pipeline i.e. the asset-heavy side of the business. Lemon Tree keeps the brands, the management contracts and the fee income i.e. it becomes the asset-light business.
The Valuation Paradox: Why the Stock Dropped 22%
Here's the odd part.
Warburg's valuation of Fleur alone is higher than the market value of all of Lemon Tree: about ₹9,115 crore at ₹115 a share at the time of writing. And Lemon Tree owns 59% of Fleur and the entire fee business on top - the supposedly asset light, fast high, high margin, high-ROCE business.
What's even more strange is that since the deal first leaked on 7 January, the stock has fallen about 22%.
Either the market is missing something, or it simply does not believe Warburg's number. This article explores the valuation question and whether this demerger is investible or not.
Why Lemon Tree's Demerger Passes the 'Contrast Test'
When one listed company houses two businesses with different economics, the market tends to price the whole at a blended multiple. Investors who want one half have to buy the other too. A demerger lets each business discover its own market value, find its own shareholders and raise its own capital.
India has a long record of this working, from Bajaj Auto and Bajaj Finserv in 2008 to Edelweiss & Nuvama in 2023. In fact, our own study of 50 Indian demergers since 2022 suggests that: it works best when the two halves are genuinely different or contrasting and when the demerged businesses continue to perform well.
Lemon Tree passes the 'contrast test' at least. Its two halves differ in almost every way that matters to an investor:
* The fee business earns a percentage of hotel revenue for running hotels it does not own. It needs almost no capital, carries no debt and grows by signing contracts. Its margin is around 60%.
* The hotel-owning business buys land, builds and renovates hotels, and borrows to do it. Its margin is around 42%, and its returns depend on the hotel business cycle and on what it invests in each new asset.
One is valued like a royalty stream, the other like real estate business with an operating layer on top. Kept together, neither is priced cleanly. That is the case for the split. Whether the split creates value for you depends on the price at which you are buying both halves today, which is what this article explores.
Three Reasons Lemon Tree Is Splitting Hotels From Brands
Lemon Tree's restructuring separates what it owns from what it manages. Fleur Hotels will become the group's hotel owner and developer. It can also take hotels on leases. Lemon Tree will become a pure-play hotel management and brand company. It runs Fleur's hotels and those of third-party owners under management and franchise contracts, although it has kept just two leased hotels (202 rooms) whose leases have 6-7 years left.
Three reasons for the split
1. The fee business is being valued like a hotel owner. Today the market sees one consolidated company with about ₹1,430 crore of gross debt, a renovation bill and hotel-cycle earnings. The fee stream inside it, which needs no capital, is priced as part of that. Listed on its own, Lemon Tree can be compared with brand and management companies rather than with property owners.
2. Fleur needs its own capital. Its pipeline is large: a 610-room Aurika at Nehru Place in Delhi (estimated ₹700 crore capex over three and a half years), land at Bandra in Mumbai for a 172-room hotel, and hotels under construction at Shimla and Shillong.
Management has said Fleur could deploy up to ₹3,000 crore over 12 to 18 months, and that its debt could rise to ₹2,500-3,000 crore. Warburg's ₹960 crore is meant to fund this partly. Fleur also gets exclusive rights to all future hotel development, ownership and leasing in the group. Lemon Tree (the branding/management business) will never have to fund a building again.
3. Each investor gets the business they want. Someone who wants a growing fee income stream no longer has to own hotels and their debt. Someone who wants hotel real estate with a growth pipeline can own Fleur directly. Lemon Tree has also promised a dividend policy once the scheme is approved.
The two halves side by side
Note: Pro forma figures are management accounts "upon the scheme becoming effective", not audited.
In terms of pipeline on a consolidated basis, Lemon Tree has almost 50% capacity under development through a mix of development & leasing contracts.
Lemon Tree Hotels Consolidated Rooms pipeline
Why Lemon Tree's Fee Profit Is Flat -- And What Could Change
Three things in the above table matter for the rest of the article.
* Lemon Tree's own profit is not growing yet. Excluding its share of Fleur, pro forma profit was ₹99 crore in FY25 and ₹98 crore in FY26. Even the reported EBITDA margin figure was 60% in FY26 and 52% in the first half of FY27, after a provision for stock appreciation rights (56% before it). The latest investor presentation expects "70%+ EBITDA margins for the fee business".
So, why is profit flat?
Pro forma Lemon Tree total Revenue grew 12%, from ₹220 crore in FY25 to ₹247 crore in FY26, but profit did not. Here's why:
* One-off charges. FY26 profit is after ₹17.4 crore of extraordinary expenses: ex-gratia payments, Delhi property tax, the new Labour Code and restructuring costs.
* Corporate costs ran ahead of revenue. In May, the chairman said corporate operating expenses "have gone up", naming tech investment and senior hires in operations, marketing, revenue, digital and sales. He said these will add to revenue but with "a lag effect", while the costs hit immediately.
* A new provision for stock appreciation rights booked from the fourth quarter of FY26 cut the fee business's H1FY27 EBITDA from ₹73 crore to ₹68 crore. First-half profit before Fleur's share was flat at ₹42 crore even though revenue rose 26%.
From here onwards, the outlook is better. Management expects "this 60% will become 70% and maybe 1 day it will be 75% to 80%. That is when all the hotels that we are signing start giving us fee income."
Given the above context, the key question is: Is there a large enough hotel pipeline that could support fee income growth?
Yes, and it is large relative to today's base.
* Rooms: about 12,100 rooms in operation across 138 hotels (including Fleur's), and another 11,930 rooms in 147 hotels signed and under development (Q2 FY27).
* Signings and openings: about 5,000 rooms signed in FY26. Management targets about 2,000 room openings in FY27; 825 rooms in 8 hotels opened in Q2 alone. It expects to open about 5,000 managed rooms in FY29 alone, roughly 45% of today's managed inventory.
* Early evidence: in Q1 FY27, fees from third-party hotels grew 42% (₹16 crore to ₹23 crore), against supply growth of 15-16%.
* Fee Income expectations: On the Q1 FY26 conference call (11 August 2025, p 10), MD said, "there will be a time if we do what we want to do, then it could be Rs. 300 - Rs. 400 crore (fee income), just from Fleur (hotel pipeline) in the next 3 years."
These are management targets, however, so best taken with a pinch of salt. Timing of openings can slip often in this business, delaying the ramp-up exactly as outlined.
* Fleur is Lemon Tree's biggest customer. Of ₹170 crore of management fees in FY26, ₹96 crore, or 56%, came from Fleur. New hotel operating agreements between the two took effect on 1 April 2026. These terms decide how profit splits between the two companies, so they decide how value splits too. These terms are not public yet.
* Fleur's EBITDA is about 13% of its capital. Management puts FY26 EBITDA after all fees at about ₹550 crore on roughly ₹4,300 crore of capital deployed. Keep that number in mind for later when we discuss valuations .
Demerger Mechanics: What Shareholders Get and When Fleur Lists
The scheme has two parts, both moving hotels into Fleur.
* Part A: four Lemon Tree subsidiaries that own hotels merge into Fleur and it pays Lemon Tree with 0.58 crore new Fleur shares.
* Part B: Lemon Tree's own hotel undertaking, with its development team, is demerged into Fleur. Fleur pays Lemon Tree's shareholders directly with 5.09 crore new Fleur shares.
What you receive. For every 311 Lemon Tree shares you hold on the record date, you get 20 Fleur shares. You keep all your Lemon Tree shares.
So, you end up owning Fleur in two ways. Directly, through the Fleur shares you receive. Indirectly, through Lemon Tree, which keeps 41% of Fleur. This is different from a clean split like Piccadily's, where the new company's shareholding mirrors the parent's. Here, Lemon Tree remains Fleur's largest shareholder, and its 41% stake is a large part of what a Lemon Tree share is worth after the split.
Where we are. The scheme has cleared three checkpoints but the longest is still ahead.
* Board approval: 9 January 2026.
* Competition Commission approval: 7 April 2026. Warburg completed its purchase of APG's stake on 22 May.
* Stock exchange and SEBI observation letters: 22 September 2026, 8.4 months after board approval. The median in our 50+ demerger database is 6.2 months.
* Still to come: the NCLT process (an order convening meetings, shareholder and creditor votes, then the sanction), the record date and Fleur's listing.
On the Q1 FY27 earnings call (10 August 2026), the CFO, Kapil Sharma, said Fleur should list in the first half of 2027. Minutes later, the chairman added that "conservatively" it would be "in the late second half of next year".
Based on a study of 43 demergers in our database, the median timeline from NSE/BSE No observation certificates to NCLT Sanctions is 9.6-9.8 months. Listing of separate entities will take another 2-3 months so a total of 12-13 months. So, listing is most likely to happen in second half of CY27 i.e - around the same time next year.
Is Fleur Really Worth 18x EBITDA? Testing Warburg's $1B Mark
Everything in this demerger comes back to one number: the USD 1 billion Warburg put on Fleur. It is the only price anyone has disclosed for the hotels. So it deserves a hard look.
What USD 1 billion means. Warburg's ₹960 crore buys 10 new shares for every 100 that exist, so the USD 1 billion values Fleur at about ₹9,600 crore before the new money goes in. Add Fleur's debt of about ₹1,150 crore and the hotels carry an enterprise value of about ₹10,750 crore. Fleur's EBITDA over the twelve months to September 2026 was about ₹587 crore after renovation spend. That is about 18 times EBITDA, or 17x times before renovation.
Is 18x too rich for a hotel owner?
The evidence suggests it is. Here are four reasons why:
It is well above its peers. SAMHI, a listed owner of upper-midscale and upscale hotels, trades at about 11x EBITDA. Ventive, backed by Blackstone, trades at about 11x, Juniper at about 12x. Fleur at 18 times sits next to Chalet and ITC Hotels, which own upscale and luxury hotels.
It is above what Fleur itself plans to pay for hotels. On the May 2026 call, Lemon Tree's chairman said operating hotels are available "anywhere from 8x of EBITDA to 16x of EBITDA". In August, Fleur's chief executive said it would look at buying operating assets "between 6 to 8 multiples". A company that buys hotels at 8 to 16 times is being valued at 18 times. Maybe some premium is warranted given Lemon Tree's stellar acquisition track-record but 18x still seems rich.
It is above the market's price for all of Lemon Tree. The whole group, fee business included, trades at about 16 times EBITDA. The fee business should be worth more per rupee of EBITDA than the hotels, not less. Yet Warburg's price puts the hotels alone above the whole.
The return on capital does not support it. Fleur's EBITDA is about 13% of the roughly ₹4,300 crore of capital deployed in it. Management calls this a 12.5-13% return on capital, but that is before depreciation. On a proper ROCE basis (EBIT over capital employed), it is closer to 10%.
Is a high number in Warburg's interest?
On new money, a higher valuation means Warburg gets fewer shares for each rupee. But in this deal, the headline doesn't cost Warburg much for four reasons:
* The new money may never all go in. The ₹960 crore is "up to", in tranches. In May the chairman said it is "entirely contingent upon availability of the right deals". A valuation applied to money that is yet to be invested is a promise, not the actual price paid.
* Warburg's real entry price is hidden. Its main investment was buying APG's 41% stake, and that price has not been disclosed. Asked on the August call what value the hotels were transferred at, the chairman said investors could "work back from" the shareholding percentages.
* The listing is Warburg's exit. A USD 1 billion reference point anchors the price at which Fleur first trades.
* Lemon Tree benefits from the same anchor. A high value for Fleur makes the fee business left behind look cheap.
Both sides gain from a high headline number. The terms of the shareholders' agreement between Warburg, Fleur, Lemon Tree and the promoter are also not public, so we cannot tell whether Warburg has any protection if Fleur lists lower.
The case for the number
There is a fair argument on the other side. Fleur's EBITDA does not yet include its largest projects: Nehru Place (610 rooms), Bandra (172 rooms), Shimla, Shillong and Varanasi. The chairman argues that India is not yet in a hotel up-cycle, with national occupancy in the mid-60s, so today's EBITDA is not a peak. And Warburg is a sophisticated buyer that has backed this management before. If the pipeline delivers, 18 times today's EBITDA could look reasonable in three years.
But that is a bet on execution and on the cycle, not a discount. The minority investor should not assume Warburg's price is the floor.
The Valuation Math -- Is There Value?
Instead of doing a sum-of-the-parts valuation from ground up, let's take the price of ₹115 (at the time of writing), subtract the value of the Fleur shares that come with each Lemon Tree share, and see what is the implied value Mr. Market is assigning to the residual Lemon Tree (Fee/Management business).
Two additional factors to consider here:
First, Lemon Tree will own 41% of Fleur directly, which may trade at a holding-company discount. Second, the fee business's profit depends on fee terms with Fleur that nobody outside has seen.
Where the value could come from. Three things would close the gap:
* Disclosure of the fee terms between Lemon Tree and Fleur, showing that the fee stream is durable and priced at market.
* Fee-business growth. Management says it signed about 5,000 rooms in FY26 and expects to open around 5,000 managed rooms by FY29. If profit grows from ₹98 crore toward ₹150 crore, today's stub price looks very different.
* Fleur's listing price. If Fleur lists near Warburg's mark, the stub will be visibly cheap and the market will have to re-rate it.
In conclusion, this demerger will put a public price on Lemon Tree's hotel assets explicitly for the first time. It will also give India its first sizable listed hotel company that earns almost entirely from brands and management fees. Every other listed Indian hotel company owns or leases hotels. With no domestic peer to compare it with, the market will have to look to Marriott, Hilton and IHG for a yardstick, and Lemon Tree will have to show fee growth to earn anything close to their multiples.
Until that price exists, Lemon Tree is cheap only if you believe Warburg's USD 1 billion.
Notes, Disclaimer and Disclosure
Data note: Company figures are from Lemon Tree's investor presentations (Q4 FY25 to Q2 FY27), the scheme presentation of 9 January 2026, earnings call transcripts, annual reports, rating rationales and NSE filings. Pro forma figures for Lemon Tree and Fleur are management accounts, not audited. Market prices and peer multiples are from Thurro (source: CMOTS) and move daily; refresh them at publication.
The purpose of this article is only to share interesting charts, data points and thought-provoking opinions. It is NOT a recommendation. If you wish to consider an investment, you are strongly advised to consult your advisor. This article is strictly for educational purposes only.
Rahul Rao has been investing since 2014. He has helped conduct financial literacy programs for over 1,50,000 investors. He helped start a family office for a 50-year-old conglomerate and worked at an AIF, focusing on small and mid-cap opportunities. He evaluates stocks using an evidence-based, first-principles approach as opposed to comforting narratives.
Disclosure: The writer or his dependents do NOT hold shares in the securities discussed in this article. The content and interpretation of data are solely the personal views of the author.
